Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Clinical Success Rate
    100.0%

    Based on 6 completed trials

    Completion Rate
    100%(6/6)
    Active Trials
    0(0%)
    Results Posted
    0%(0 trials)

    Phase Distribution

    Phase 1
    1
    14%
    Not Applicable
    5
    71%

    Phase Distribution

    1

    Early Stage

    0

    Mid Stage

    0

    Late Stage

    Phase Distribution6 total trials
    Phase 1Safety & dosage
    1(16.7%)
    N/ANon-phased studies
    5(83.3%)

    Highest Phase Reached

    Phase 1

    Trial Status & Enrollment

    Completion Rate

    100.0%

    6 of 6 finished

    Non-Completion Rate

    0.0%

    0 ended early

    Currently Active

    0

    trials recruiting

    Total Trials

    7

    all time

    Status Distribution
    Completed(6)
    Other(1)

    Detailed Status

    Completed6
    unknown1

    Development Timeline

    Analytics

    Development Status

    Total Trials
    7
    Active
    0
    Success Rate
    100.0%
    Most Advanced
    Phase 1

    Trials by Phase

    Phase 11 (16.7%)
    N/A5 (83.3%)

    Trials by Status

    unknown114%
    completed686%

    Recent Activity

    0 active trials
    Showing 5 of 7
    completednot_applicable

    Circulating Ghrelin as a Biomarker for Dementia

    NCT05381090
    unknown

    Adenomyosis Patients With Infertility and Immunological Factors

    NCT06123975
    completednot_applicable

    Changes in Metabolic Rate and Perceptual Indicators After Acute Ingestion of Paraxanthine

    NCT05811923
    completednot_applicable

    Developing a Portable Therapeutic Baby Nest for Newborns and Evaluation During Venous Blood Collection

    NCT05442619
    completednot_applicable

    Quantification of Clinically Relevant Drug Induced Changes in HbO2 Affinity

    NCT04612270
    View all 7 trials

    Clinical Trials (7)

    Showing 7 of 7 trials
    NCT05381090Not Applicable

    Circulating Ghrelin as a Biomarker for Dementia

    Completed
    NCT06123975

    Adenomyosis Patients With Infertility and Immunological Factors

    Unknown
    NCT05811923Not Applicable

    Changes in Metabolic Rate and Perceptual Indicators After Acute Ingestion of Paraxanthine

    Completed
    NCT05442619Not Applicable

    Developing a Portable Therapeutic Baby Nest for Newborns and Evaluation During Venous Blood Collection

    Completed
    NCT04612270Not Applicable

    Quantification of Clinically Relevant Drug Induced Changes in HbO2 Affinity

    Completed
    NCT03970434Phase 1

    Drug Concentration of Metformin According to Sampling Method

    Completed
    NCT02854475Not Applicable

    Confocal Raman Spectroscopy: in Vivo Measurement of Physiological Skin Parameters

    Completed

    All 7 trials loaded

    Drug Details

    Intervention Type
    Varies by study
    Total Trials
    7